tert-Butyl N-[(3S,6R)-6-methylpiperidin-3-yl]carbamate, 98%, 1g

6,7-Dihydrobenzo[b]thiophen-4-one, 95.0%, 5g

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 100, 4000 ml, 250 mm, 1 pieza

N-(4-Bromophenyl)-methanesulfonamide, 95.0%, 5g

7-(4-Bromobenzoyl)indolin-2-one, 98%, 250mg

4-[(4-Bromophenyl)sulfonyl]piperidinehydrochloride, 90.0%, 5g

2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>97.0%(GC)(T)25g

7-BROMO-3-IODOIMIDAZO[1,2-A]PYRIDINE, 95.0%, 250mg

Tert-butyl (3S,4S)-3-(hydroxymethyl)-4-methylpyrrolidine-1-carboxylate, 98+%, 500mg

N-(3-(1H-INDOL-5-YL)-1H-INDAZOL-5-YL)-2,6-DICHLOROBENZAMIDE, 95%, 50mg

2-(2-Bromophenyl)oxirane, 5g

NITRENDIPINE, 95%, 5g

5-(Thiophen-2-yl)nicotinic Acid, 97.0%, 1g